Preparation method and application of disulfide wet adhesion hydrogel
Through the preparation of disulfide functional monomers and electrospinning technology, the problem of slow adhesion speed and insufficient stability of hydrogel-based wet adhesives is solved, real-time adhesion and long-term stability are achieved, and the biological phase is passed Capacitive trigger solution enables adjustable separation, suitable for a variety of tissue repair needs.
Patent Information
- Application Number
- CN202411120348.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-26
AI Technical Summary
Existing hydrogel-based medical wet adhesives have problems such as slow adhesion formation speed, insufficient long-term stability and strength, difficulty in separation on demand, and mismatch of mechanical properties.
Using the preparation method of functional disulfide monomers, the solvent is removed by magnetic stirring and vacuum to form a wet adhesion hydrogel with a semi-interpenetrating network structure, and real-time adhesion and long-term stability are achieved using physical and covalent crosslinking mechanisms. , and the nanofiber structure is imparted through electrospinning technology, combining biocompatible trigger solution to achieve adjustable separation.
It achieves immediate adhesion, long-term stability and strength improvement in short-term, and has adjustable separation capabilities and good biocompatibility, which is suitable for tissue repair at different time scales.
Smart Images

Figure CN119015476A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a preparation method and application of a disulfide wet adhesion hydrogel. Background Art
[0002] Every year, countless patients suffer from minor skin injuries or severe tissue damage. Choosing the right solution and wound treatment can effectively avoid wound infection, reduce fluid loss, and promote the recovery of tissue structure and function at the wound site. In clinical medicine, wound treatment mainly includes reconnecting injured tissues and closing wound edges. In traditional medical practice, sutures or tissue fixation nails are usually used to promote wound closure, so that the tissue structure is closely connected and can withstand a certain mechanical force to prevent wound dehiscence. Although suture treatment greatly reduces the exposure area of the wound and the risk of wound infection, there are some situations where suture is not applicable, such as: organs or soft tissues with complex external and internal fine structures may leak liquid or air; large wounds are difficult to achieve effective closure using sutures, and the suture process often takes a long time, increasing the risk of wound infection and postoperative complications. With the continuous development of modern medical technology and the gradual development of new materials, wet adhesives such as tissue adhesives, hemostats and tissue sealants (usually suitable for wet environments caused by blood and body fluids) have gradually replaced traditional sutures and tissue fixation nails to strongly adhere to tissues to achieve wound closure or sealing. Medical wet adhesives that have been clinically approved in the past few decades include bio-based materials, cyanoacrylates, and polymer hydrogels. Among them, hydrogel medical wet adhesives are called bioadhesive hydrogels because of their inherent tissue adhesion. Compared with other wet adhesives, bioadhesive hydrogels have been widely studied because of their biological tissue structure, strong tissue adhesion, easy availability, adjustable mechanical properties, and good biocompatibility. Cited by Taboada GM, Yang KS, Pereira M JN, et al. Overcoming the translational barriers of tissue adhesives Nature Reviews Materials. 5(4), 310-329(2020). However, most hydrogel medical wet adhesives have inherent limitations, including slow adhesion formation and lack of triggerable benign detachment. For example, Xie et al. first synthesized a hyperbranched polymer named HB-PBAE through the Michael addition reaction between dopamine (DOPA), poly (ethylene glycol) diacrylate (PEGDA 700) and pentaerythritol triacrylate (PETA).Then, DOPA-based adhesive hydrogels are prepared by mixing HB-PBAE, poly (1-vinyl imidazole) (PVI), gelatin and Fe 3+. Although the adhesive reduces the probability of damage caused by wound replacement, the process of forming adhesion is relatively slow, and the stability and strength of long-term adhesion need to be considered, citing Xie T, Ding J, Han XX et al., Wound dressing change facilitated by spraying zinc ions. Mater. Horiz. 7, 605-614 (2020). In order to obtain an ideal medical wet adhesive hydrogel, the present invention provides a method for preparing a composite hydrogel containing a cleavable functional monomer, and endows the wet adhesive material with a new structural feature and a unique adhesion mechanism, that is, the composite hydrogel with a semi-interpenetrating network structure removes interfacial water from the wet tissue surface, and within a short time range, the wet adhesive hydrogel produces instant physical crosslinking. In the long term, the cleavable functional monomers in the wet adhesive hydrogel form covalent crosslinks with the surface of the biological tissue, further improving the stability and strength of the long-term adhesion. Secondly, the wet-adhesive hydrogel can meet different triggering separation requirements at different time scales. It can readjust the mispositioned wet-adhesive hydrogel immediately after adhesion, or trigger separation in a more efficient, biocompatible, and non-secondary wound-injury manner over a wider time range. Finally, the electrospinning technology is used to give the wet-adhesive material an extracellular matrix-like nanofiber structure, which is easier for cell growth and tissue repair.
[0003] In the process of realizing the specific functions of wet adhesive materials, the modification process of raw materials is relatively complicated. In addition, in the process of material application, most commercially available wet adhesive materials have inherent defects such as long adhesion formation time, weak tissue bonding ability, mismatched mechanical properties, low biocompatibility or inability to benignly detach.
[0004] The purpose of the present invention is to provide a disulfide wet adhesive patch and its preparation method and application in order to overcome the defects of the above-mentioned existing materials, so as to simplify the modification process and purification method of the raw materials, quickly adhere to the moist tissue surface or wound to form a tough adhesive film, and separate the wet adhesive from the adhered tissue surface or wound without damage as needed, and further optimize the existence form of the wet adhesive material, obtain an extracellular matrix-like nanofiber membrane, and conduct practical application tests. Summary of the invention
[0005] The technical problems to be solved by the present invention are mainly to simplify the modification and purification methods of functional monomers, accelerate the adhesion formation speed of wet adhesion patches, enhance the flexibility and mechanical properties of wet adhesion patches, separate them on demand from adhered tissue surfaces or wounds without secondary damage, and optimize the structural morphology and existence form of wet adhesion materials to obtain extracellular matrix-like nanofiber membranes.
[0006] The present invention simplifies the modification and purification process of the cleavable functional monomer, saves the process cost of the pilot scale-up and other conversion processes, and is easier to successfully convert in the actual application process.
[0007] The wet adhesive hydrogel of the present invention can achieve instant (5s-30s) super strong adhesion on a variety of wet dynamic tissue surfaces, and can achieve beneficial on-demand separation by using a trigger solution with biocompatibility.
[0008] The adhesion mechanism of the wet adhesion hydrogel of the present invention relies on removing the interfacial water on the wet biological tissue surface and then physically and covalently cross-linking with the tissue surface, further improving the stability and strength of long-term adhesion.
[0009] The wet adhesive hydrogel of the present invention can be transformed into a tough hydrogel having mechanical compliance and stretchability comparable to that of soft tissue after contacting with a wet biological tissue surface.
[0010] The present invention adopts electrostatic spinning technology to optimize the structure of the wet adhesive patch so that it has a nanofiber structure similar to the extracellular matrix, which is beneficial to cell growth and tissue repair.
[0011] The present invention uses isolated chicken hearts to verify the wet adhesion hydrogel and the trigger solution, proving that it has triggerable benign detachment ability. The first object of the present invention is to provide a method for preparing a disulfide functional monomer, comprising the following steps:
[0012] (1) The disulfide monomer and acetic anhydride were added to a round-bottom flask equipped with a magnetic stirring bar, and the mixture was magnetically stirred at room temperature until the mixture was completely dissolved. Then, the unreacted solvent was removed by vacuum.
[0013] (2) 4-Dimethylaminopyridine (DMAP) and hydroxyethyl methacrylate (HEMA) were dissolved in anhydrous dichloromethane (DCM) and magnetically stirred at room temperature to allow DMAP to activate the hydroxyl groups in HEMA.
[0014] (3) Dissolve the product obtained in step (1) in anhydrous DCM and slowly transfer it to the mixed solution of step (2), and stir magnetically overnight.
[0015] (4) Saturated sodium bicarbonate (NaHCO3) solution was added to complete the reaction of step (3), and the mixture was acidified to pH = 2.0 with hydrochloric acid (HCl), and extracted with DCM. The organic phase was dried over anhydrous sodium sulfate (Na2SO4), filtered and concentrated in vacuo, and the crude product was passed through a silica gel chromatography column ( Figure 1 ) and finally concentrated in vacuo.
[0016] (5) The oily liquid obtained in step (4) was then dissolved in anhydrous DCM and stirred with N-hydroxysuccinimide (NHS) in an ice bath.
[0017] (6) 1-Ethyl-(3-(dimethylaminopropyl)carbodiimide hydrochloride) (EDC) dissolved in anhydrous DCM was added dropwise to the above mixture and stirred magnetically under nitrogen atmosphere at room temperature overnight.
[0018] (7) The mixed solution is added dropwise into petroleum ether as a precipitant to obtain white floccules, which are then washed with ultrapure water, filtered and dried to obtain a powdery disulfide functional monomer.
[0019] Preferably, the disulfide monomer in step (1) may be diphenyl disulfide (Ph2S2), dimethyl disulfide (CH3-SS-CH3), diallyl disulfide (H2C=CH-CH2S-SCH2-CH=CH2), dithioglycolic acid (C4H6O4S2), cystine, α-lipoic acid and asparagus acid;
[0020] Further preferably, the concentration of the disulfide monomer in step (1) is 5×10-3 to 2×10-2 mol / L;
[0021] Preferably, the volume of acetic anhydride in step (1) is 5 to 30 mL;
[0022] Further preferably, the stirring rate in step (1) is 200 to 600 rpm and the time is 2 to 6 hours.
[0023] Preferably, the apparatus used for vacuum removal of the solvent in step (1) is a RE-52AA rotary evaporator equipped with a 2XZ-4 rotary vane vacuum pump and a DLSB-5L / 20 low-temperature coolant circulation pump; More preferably, the cooling temperature of the rotary evaporation is -20°C, the water bath heating temperature is 30-60°C, and the rotation speed is 30-120 r / min.
[0024] Preferably, the mass of 4-dimethylaminopyridine (DMAP) in step (2) is 0.01 to 0.03 g;
[0025] Preferably, the concentration of hydroxyethyl methacrylate (HEMA) in step (2) is 5×10-3 to 2×10-2 mol / L;
[0026] Preferably, the volume of anhydrous dichloromethane (DCM) in step (2) is 8 to 20 mL; further preferably, the stirring rate in step (2) is 300 to 600 rpm, and the time is 0.5 to 2 h.
[0027] Preferably, the volume of anhydrous DCM in step (3) is 8 to 20 mL;
[0028] Further preferably, the stirring rate in step (3) is 300-600 rpm and the time is 12-18 h.
[0029] Preferably, the volume of saturated sodium bicarbonate (NaHCO3) in step (4) is 20 to 60 mL;
[0030] Preferably, the concentration of hydrochloric acid (HCl) in step (4) is 1 to 10 mol / L;
[0031] Preferably, the apparatus used for vacuum concentration in step (4) is a RE-52AA rotary evaporator equipped with a 2XZ-4 rotary vane vacuum pump and a DLSB-5L / 20 low-temperature coolant circulation pump;
[0032] More preferably, the cooling temperature of the rotary evaporation is -20°C, the water bath heating temperature is 30-60°C, and the rotation speed is 30-120 r / min.
[0033] Preferably, the volume ratio of methanol (MeOH) and DCM used as eluents in step (4) is 1:500 to 1:20.
[0034] Preferably, the volume of anhydrous DCM in step (5) is 10 to 40 mL;
[0035] Preferably, the concentration of N-hydroxysuccinimide (NHS) in step (5) is 5×10-3 to 2×10-2 mol / L;
[0036] Further preferably, the stirring rate in step (5) is 300-600 rpm and the time is 0.5-2 h.
[0037] Preferably, the volume of anhydrous DCM in step (6) is 5 to 20 mL;
[0038] Preferably, the concentration of 1-ethyl-(3-(dimethylaminopropyl)carbodiimide hydrochloride (EDC) in step (6) is 5×10-3 to 2×10-2 mol / L;
[0039] Further preferably, the stirring rate in step (6) is 300-600 rpm and the time is 12-18 h.
[0040] Preferably, the volume of petroleum ether in step (7) is 300-500 mL;
[0041] Preferably, the ultrapure water in step (7) is derived from a ULUP-IV-20TE model ultrapure water machine;
[0042] Further preferably, the volume of the ultrapure water in step (7) is 300 to 500 mL;
[0043] Further preferably, the ultrapure water washing in step (7) is carried out under ultrasonic treatment for 30 min to 2 h.
[0044] The second object of the present invention is to provide a method for gelling the disulfide functional monomer prepared by the above preparation method, comprising the following steps:
[0045] (1) Dissolve polyvinyl alcohol 1788 (PVA) in deionized water under heating conditions. Add acrylic acid, photoinitiator and crosslinking agent to the mixed solution in sequence and stir magnetically until completely dissolved.
[0046] (2) Dissolve the disulfide functional monomer in acetone and add it to the above stock solution and stir it magnetically to obtain a precursor solution. Inject the precursor solution into a glass mold ( Figure 2 ) and cured under ultraviolet light to obtain a wet-adhesive hydrogel with disulfide functional monomers.
[0047] Preferably, the heating temperature in step (1) is 60-80°C;
[0048] Preferably, the mass percentage of polyvinyl alcohol 1788 (PVA) in step (1) is 7 to 14 wt %;
[0049] Preferably, the mass percentage of acrylic acid in step (1) is 14 to 35 wt %;
[0050] Preferably, the photoinitiator in step (1) can be 2-hydroxy-2-methylpropiophenone (1173), dialkoxyacetophenone, α-hydroxyalkyl phenone, α-aminoalkyl phenone, α-ketoglutaric acid, benzophenone, 4-methylbenzophenone, 2,4,6-trimethylbenzophenone;
[0051] Further preferably, the mass percentage of the photoinitiator in step (1) is 0.1 to 1 wt %; preferably, the crosslinking agent in step (1) may be 2,5-dimethyl-2,5-di(tert-butylperoxy)hexane (AD), methylenebis(o-chloroaniline) (MOCA), quinonedioxime (QO), poly(ethylene glycol) methacrylate, poly(ethylene glycol) dimethacrylate, diisocyanate, bismaleimide and triallyl isocyanate;
[0052] Further preferably, the mass percentage of the cross-linking agent in step (1) is 0.01 to 0.1 wt %;
[0053] Further preferably, the stirring rate in step (1) is 600-1000 rpm and the time is 5-30 min.
[0054] Preferably, the mass of the NHS ester functionalized monomer having a disulfide bond in step (2) is 25 to 300 mg;
[0055] Preferably, the volume of acetone in step (2) is 0.5 to 3 mL;
[0056] Preferably, the instrument used for the ultraviolet curing in step (2) is a SCIENTZ03-II type ultraviolet cross-linking instrument;
[0057] More preferably, the UV cross-linking device used in step (2) is used for photocuring for 15 to 30 minutes.
[0058] Further preferably, the stirring rate in step (1) is 600-1000 rpm and the time is 5-30 min.
[0059] The third object of the present invention is to provide an application of the wet adhesive hydrogel, wherein the dry wet adhesive patch is used for rapid hemostasis and repair of moist tissue and organ surfaces, and the components of the hydrogel in the adhesive layer of the wet adhesive patch (after contacting water) will form covalent bonds and hydrogen bonds at the junction when encountering the moist tissue surface, so as to achieve the purpose of tight adhesion and firm bonding.
[0060] A fourth object of the present invention is to provide a biocompatible triggered separation of the wet adhesion hydrogel ( Figure 3 ), since the adhesion mechanism of wet adhesion hydrogel relies on first removing the interfacial water on the wet biological tissue surface and then physically and covalently cross-linking with the tissue surface, triggerable separation requires the use of a trigger solution to cut off the cross-linking force between the wet adhesion hydrogel and the biological tissue surface. The configuration method of the trigger solution is as follows:
[0061] (1) A certain amount of sodium bicarbonate (SBC) and glutathione (reduced form) (GSH) were dissolved in phosphate buffered saline (PBS).
[0062] (2) Using a rubber-tipped dropper, take a portion of the trigger solution and apply it to the wet-adhesive hydrogel that has adhered to the surface of the biological tissue. After standing, use tweezers to peel off the triggered wet-adhesive hydrogel.
[0063] Preferably, the concentration of sodium bicarbonate (SBC) in step (1) is 5×10-1 to 10 mol / L;
[0064] Preferably, the concentration of glutathione (reduced form) in step (1) is 5×10-2 to 1 mol / L;
[0065] Preferably, the concentration of the phosphate buffer (PBS) in step (1) is 1×10-2 to 1 mol / L, and the pH is 6.0 to 8.0.
[0066] Preferably, the standing time in step (2) is 5 to 45 minutes.
[0067] The present invention forms adhesion force by means of physical crosslinking and covalent crosslinking bonding between wet adhesion hydrogel and wet biological tissue surface. There are large differences in the contribution of these two bonding modes to adhesion force at different time scales. Specifically, in the time range of 30s to 10min (short term), the semi-interpenetrating network structure composed of cleavable disulfide functional monomers and polyvinyl alcohol 1788 (PVA) and polyacrylic acid (PAA) will first remove interfacial water from the wet tissue surface, so that the wet adhesion hydrogel has instant physical crosslinking (such as hydrogen bonding and van der Waals force) ability, and plays a leading role in the adhesion between the wet adhesion hydrogel and the wet biological tissue surface. However, as time goes by, due to the equilibrium state generated by the gradual neutralization of the carboxylic acid groups in the wet adhesion hydrogel, the contribution of physical crosslinking to adhesion gradually decreases, weakening the physical crosslinking force formed between the wet adhesion hydrogel and the wet biological tissue surface. Therefore, in the long term, the cleavable disulfide functional monomers in the wet adhesive hydrogel will form covalent cross-linking (such as amide bonds) forces with the primary amine groups on the surface of biological tissues, and gradually deepen the degree of adhesion contribution to the surface of biological tissues, further improving the stability and strength of long-term adhesion. In addition, the wet adhesive hydrogel can meet different triggering separation requirements on different time scales, enabling it to readjust the mispositioned wet adhesive hydrogel immediately after adhesion or trigger separation in an efficient, biocompatible and non-secondary wound-injury manner within a wide time range (minutes to hours). BRIEF DESCRIPTION OF THE DRAWINGS
[0068] Figure 1 The present invention provides a schematic structural diagram of a silica gel chromatography column.
[0069] Figure 2 A schematic diagram of a light-cured glass mold for a wet-adhesive hydrogel containing a disulfide functional monomer provided by the present invention.
[0070] Figure 3 Schematic diagram of wet adhesion and triggered separation of the disulfide wet adhesion patch provided by the present invention.
[0071] Figure 4 This is a nuclear magnetic resonance test image of the disulfide functional monomer provided by the present invention, and illustration i is a white powdery disulfide functional monomer.
[0072] Figure 5 Adhesion and triggered detachment experiments of wet adhesive patches with disulfide functional monomers provided by the present invention. DETAILED DESCRIPTION
[0073] The present invention is described in detail below in conjunction with the accompanying drawings and specific embodiments. The following embodiments will help those skilled in the art to further understand the present invention, but are not intended to limit the present invention in any form. It should be noted that, for those of ordinary skill in the art, several variations and improvements may be made without departing from the concept of the present invention. These all belong to the protection scope of the present invention.
[0074] Any features such as preparation methods, materials, structures or composition ratios that are not clearly described in this technical solution shall be deemed as common technical features disclosed in the prior art.
[0075] In the present invention, the main functional component of the wet adhesive patch having disulfide functional monomers is [-C14H18O8NS2-]n.
[0076] In the present invention, the raw materials used for preparing ordinary concrete are: dithioglycolic acid (C4H6O4S2, 96%), hydroxyethyl methacrylate (HEMA, C6H10O3, 96%), benzophenone (C13H10O, AR), 2-hydroxy-2-methylpropiophenone (1173, C10H12O2, 97%) and 1-ethyl-(3-(dimethylaminopropyl)carbodiimide hydrochloride (EDC, C8H18ClN3, 98%); acetic anhydride ((CH3CO) 2O, 98.5%); anhydrous dichloromethane (DCM, CH2Cl2, 99.9%, water <30ppm); petroleum ether (30℃~60℃), acetone (CH3COCH3, 99.5%), sodium bicarbonate (SBC, NaHCO3, 99.5%), quartz sand (SiO2, 40~80 mesh, 99%), anhydrous sodium sulfate (Na2SO4, 99%), hydrochloric acid (HCl, 36%~38%), disodium hydrogen phosphate (Na2HPO4, 99.5%) and Sodium dihydrogen phosphate (NaH2PO4, 99.5%); methanol (MeOH, CH3OH, 99.5%), acrylic acid (C3H4O2, 99%), column chromatography silica gel (200-300 mesh 54-75 μm), 4-dimethylaminopyridine (DMAP, C7H10N2, 99%), poly (ethylene glycol) methacrylate (H2C=C(CH3)CO(OCH2CH2)nOH, average molecular weight ~500), N-hydroxysuccinimide (NHS, C4H5NO3, 98%), polyacrylic acid ((C3H4O2)n, average molecular weight ~450000), polyvinyl alcohol 1788 type (PVA, [-CH2CHOH-]n, alcoholysis degree: 87~89%) and glutathione (reduced form) (GSH, C10H17N3O6S, 98%); poly(ethylene glycol) dimethacrylate (average molecular weight ~500, 99.9%); deionized water and ultrapure water were all from ULUP-IV-20TE model ultrapure water machine.
[0077] Example 1
[0078] This embodiment provides a method for preparing a disulfide functional monomer, comprising the following steps:
[0079] (1) 1×10-2 mol / L of dithioglycolic acid and 16 mL of acetic anhydride were added to a round-bottom flask equipped with a magnetic stirring bar, and magnetically stirred at 350 rpm for 3 h at room temperature to completely dissolve the mixed solution. Then, the remaining acetic anhydride was removed by vacuum using a RE-52AA rotary evaporator equipped with a 2XZ-4 rotary vane vacuum pump and a DLSB-5L / 20 low-temperature coolant circulation pump, wherein the cooling temperature of the rotary evaporation was -20°C, the water bath heating temperature was 40°C, and the rotation speed was 100 r / min. Finally, a colorless oily 1,4,5-oxadithiophene-2,7-dione was obtained.
[0080] (2) Dissolve 0.015 g of 4-dimethylaminopyridine (DMAP) and 1×10-2 mol / L of hydroxyethyl methacrylate (HEMA) in anhydrous dichloromethane (DCM), and stir the mixture at 400 rpm for 0.5 h at room temperature to ensure that 4-dimethylaminopyridine (DMAP) can completely activate the hydroxyl groups in hydroxyethyl methacrylate (HEMA). Dissolve the colorless oil obtained in step (1) in anhydrous DCM, and slowly transfer it to the mixed solution of step (2), and stir the mixture at 400 rpm overnight. The total volume of anhydrous dichloromethane (DCM) is 15 mL.
[0081] (3) Add 30 mL of saturated sodium bicarbonate (NaHCO3) solution to the mixed solution of step (2) until no bubbles are generated during stirring, then acidify the mixture to pH = 2.0 with 1 mol / L hydrochloric acid (HCl), and extract with DCM. Then, dry the organic phase with an appropriate amount of anhydrous sodium sulfate (Na2SO4) to remove excess water, filter with a sand core funnel to separate the solid and liquid, and use a RE-52AA rotary evaporator equipped with a 2XZ-4 rotary vane vacuum pump and a DLSB-5L / 20 low-temperature coolant circulation pump, wherein the cooling temperature of the rotary evaporation is -20°C, the water bath heating temperature is 40°C, and the rotation speed is 100 r / min. Finally, the crude product was purified by silica gel chromatography using a mixture of methanol (MeOH) and DCM as an eluent, and then concentrated in vacuo to obtain pink oily 6-(2-(methacryloyloxy)ethoxy)hept-6-enoic acid, wherein the volume of methanol (MeOH) and DCM was gradually increased from 1:500 to 1:20, and the instrument used for vacuum concentration was a RE-52AA rotary evaporator equipped with a 2XZ-4 rotary vane vacuum pump and a DLSB-5L / 20 low-temperature coolant circulation pump. The cooling temperature of the rotary evaporation was -20°C, the water bath heating temperature was 40°C, and the rotation speed was 100 r / min.
[0082] Figure 1This is a schematic diagram of the structure of the silica gel chromatography column provided by the present invention. The glass chromatography column is filled from bottom to top with medical cotton wool, quartz sand (SiO2, 40-80 mesh), a DCM+MeOH mixed solution of column chromatography silica gel (200-300 mesh), 6-(2-(methacryloyloxy)ethoxy)hept-6-enoic acid to be purified and quartz sand (SiO2, 40-80 mesh). It should be noted that the boundaries between the layers of fillers should be smooth, otherwise the separation rate of the sample to be purified will be inconsistent.
[0083] (4) Then, 6-(2-(methacryloyloxy)ethoxy)hept-6-enoic acid was dissolved in anhydrous DCM and stirred with 1×10-2 mol / L N-hydroxysuccinimide (NHS) in an ice bath, wherein the stirring rate was 470 rpm for 0.5 h. Then, 1×10-2 mol / L 1-ethyl-(3-(dimethylaminopropyl)carbodiimide hydrochloride (EDC) dissolved in anhydrous DCM was added dropwise to the above mixture, and the mixture was stirred magnetically overnight under a nitrogen atmosphere at room temperature to obtain a yellow mixed solution. The total volume of anhydrous DCM was 30 mL.
[0084] (5) The mixed solution was added dropwise to petroleum ether as a precipitant to obtain a white flocculent, which was then ultrasonically washed with ultrapure water for 30 minutes, the waste liquid was filtered out, and the mixture was dried at room temperature to obtain a disulfide functional monomer in the form of a white powder. The volume of petroleum ether was 500 mL, and the volume of ultrapure water was 500 mL.
[0085] This embodiment provides a method for gelling a disulfide functional monomer, comprising the following steps:
[0086] (1) After 7 wt % of polyvinyl alcohol 1788 (PVA) was dissolved in deionized water at 80° C., 35 wt % of acrylic acid, 0.2 wt % of 2-hydroxy-2-methylpropiophenone (1173) and 0.1 wt % of poly(ethylene glycol) methacrylate were added to the mixed solution in sequence, and the mixture was stirred at room temperature at 1000 rpm for 5 min.
[0087] (2) Dissolve 50 mg of disulfide functional monomer in 500 μL of acetone and add it to the above stock solution and stir it magnetically until it is completely dissolved to obtain a precursor solution. Inject 200 μL of the precursor solution into a glass mold with a certain spacing ( Figure 2 ) and cured in a SCIENTZ03-II type UV cross-linking instrument under UV light for 30 min to obtain a wet adhesion hydrogel with disulfide functional monomers.
[0088] Figure 2Schematic diagram of a light-cured glass mold for wet-adhesive hydrogel with disulfide functional monomers provided by the present invention. The upper and lower layers of the mold are both 250×750 mm glass sheets, and the middle interlayer is a double-sided tape of appropriate thickness to connect the two glass sheets in an offset manner, which is convenient for subsequent separation of the mold and removal of the wet-adhesive hydrogel.
[0089] The dry wet adhesive hydrogel was placed on the wet chicken heart surface and pressed for 5 seconds. The adhesive layer of the wet adhesive hydrogel quickly formed hydrogen bonds and covalent crosslinks at the junction after contacting water, showing a tight and strong adhesive force.
[0090] Figure 3 The present invention is a schematic diagram of the adhesion and separation structure between the disulfide wet adhesion patch and the wet biological tissue provided by the present invention, which specifically shows that the water on the surface of the biological tissue will spontaneously penetrate into the network of the hydrogel, so that the junction of the two forms hydrogen bonds and covalent cross-linking to achieve the effect of rapid hemostasis and repair, and then the cross-linking force is cut off by phosphate buffered saline (PBS) containing sodium bicarbonate (SBC) and glutathione (reduced form) (GSH), so that the disulfide wet adhesion hydrogel can be efficiently peeled off. This example provides a biocompatible triggered separation of the wet-adhesive hydrogel, and the configuration method of the trigger solution is as follows:
[0091] (1) 0.5 mol / L sodium bicarbonate (SBC) and 0.05 mol / L glutathione (reduced form) (GSH) were dissolved in 0.01 M phosphate buffered saline (PBS) (pH = 6.8), respectively.
[0092] (2) Use a rubber-tipped dropper to apply a portion of the trigger solution to the wet-adherent hydrogel that has adhered to the surface of the biological tissue. After standing for 10 minutes, use tweezers to peel off the triggered wet-adherent hydrogel. The disulfide functional monomer in this example was verified by nuclear magnetic resonance. The test results are as follows: Figure 4 As shown, the peak position and coverage area of each absorption peak can correspond to the type of hydrogen group and the number of hydrogen nuclei that cause the absorption (see the annotations in the spectrum for details), indicating that the functional properties of disulfide have been successfully prepared. Illustration i is a white powdery disulfide functional monomer.
[0093] A simple adhesion and triggered detachment experiment was performed on the wet adhesion patch with disulfide functional monomers in this example. Figure 5 a is a wet adhesive patch with disulfide functional monomer obtained after UV curing and demolding, which appears macroscopically as a transparent elastomer with a certain thickness. Figure 5b is to cut the dried wet adhesive patch with disulfide functional monomer into appropriate size and place it on the wet chicken heart wound surface. The patch can be tightly combined with the wound surface and can give the chicken heart the ability to relax and contract. Phosphate buffered saline (PBS) containing sodium bicarbonate (SBC) and glutathione (reduced form) (GSH) is wet applied to the patch adhered to the chicken heart wound surface to cut off the cross-linking force at the junction, so that the wet adhesive patch with disulfide functional monomer can be detached as a whole piece, such as Figure 5 As shown in c.
[0094] Example 2
[0095] This embodiment provides a wet adhesive patch without adding disulfide functional monomer. In contrast to the above examples, in this embodiment, a disulfide functional monomer gelation method is slightly adjusted, that is, only the stock solution prepared in step (1) is used as a precursor solution and injected into a glass mold ( Figure 2 )Inside. The remaining steps are the same as those in the comparative example.
[0096] The wet adhesive patch without disulfide functional monomer prepared by the above preparation method is still a transparent elastomer of a certain thickness, but after being cut into an appropriate size and placed on the wet chicken heart wound surface, the bonding ability between the patch and the wound surface is slightly reduced, and when a phosphate buffered saline (PBS) containing sodium bicarbonate (SBC) and glutathione (reduced form) (GSH) is wet-applied on the patch adhered to the chicken heart wound surface, the wet adhesive patch is not easy to fall off.
[0097] Example 3
[0098] In this embodiment, a modification is made to provide a gelation method for a disulfide functional monomer. In this embodiment, acrylic acid, 2-hydroxy-2-methylpropiophenone (1173) and poly(ethylene glycol) dimethacrylate are replaced in turn with polyacrylic acid, benzophenone and poly(ethylene glycol) dimethacrylate in step (1), wherein the mass percentage of polyacrylic acid is 7wt%, the mass percentage of benzophenone is 0.2wt%, and the mass percentage of poly(ethylene glycol) dimethacrylate is 10wt%. In step (2), the obtained precursor solution is placed in a 10mL syringe with a metal needle, the metal needle is connected to the positive electrode, the receiving plate is used as the negative electrode, and then the distance between the two electrodes is fixed to 12cm, and then a high voltage of 16kV is applied. At the same time, the propeller speed is set to 0.2mL / h, and a nanofiber membrane is obtained by electrospinning, and then after ultraviolet curing, a nanofiber membrane with a disulfide functional monomer is obtained. The remaining steps are the same as those in the comparative example.
[0099] The nanofiber membrane with disulfide functional monomers prepared by the above preparation method still exhibits strong wet adhesion ability, and has a more breathable three-dimensional network structure compared to the hydrogel form, so it has stronger toughness and is lighter.
Claims
1. A preparation method and application of a disulfide wet adhesion hydrogel, characterized in that: The product was prepared from the following raw materials: dithioglycolic acid (C4H6O4S2, 96%), hydroxyethyl methacrylate (HEMA, C6H10O3, 96%), benzophenone (C13H10O, AR), 2-hydroxy-2-methylpropiophenone (1173, C10H12O2, 97%) and 1-ethyl-(3-(dimethylaminopropyl)carbodiimide hydrochloride (EDC, C8H18ClN3, 98%); acetic anhydride ((CH3CO)2O, 98.5%); anhydrous dichloromethane (DCM, CH2Cl2, 99.9%, water <30ppm); petroleum ether (30℃~60℃), acetone (CH3COCH3, 99.5%), sodium bicarbonate (SBC, NaHCO3, 99.5%), quartz sand (SiO2, 40~80 mesh, 99%), anhydrous sodium sulfate (Na2SO4, 99%) ), hydrochloric acid (HCl, 36%-38%), disodium hydrogen phosphate (Na2HPO4, 99.5%) and sodium dihydrogen phosphate (NaH2PO4, 99.5%); methanol (MeOH, CH3OH, 99.5%), acrylic acid (C3H4O2, 99%), column chromatography silica gel (200-300 mesh 54-75μm), 4-dimethylaminopyridine (DMAP, C7H10N2, 99%), poly(ethylene glycol) methacrylate (H2C=C(CH3)CO(OCH2CH2)nOH, average molecular weight ~500), N-hydroxysuccinimide (NHS, C4H5NO3, 98%), polyacrylic acid ((C3H4O2)n, average molecular weight ~450000), polyvinyl alcohol 1788 type (PVA, [-CH2CHOH-]n, degree of alcoholysis: 87~89%) and glutathione (reduced form) (GSH, C10H17N3O6S, 98%); poly(ethylene glycol) dimethacrylate (average molecular weight ~500, 99.9%).
2. The preparation method and application of the disulfide wet adhesion hydrogel according to claim 1, characterized in that: The steps include: (1) The disulfide monomer and acetic anhydride were added to a round-bottom flask equipped with a magnetic stirring bar, and the mixture was magnetically stirred at room temperature until the mixture was completely dissolved. Then, the unreacted solvent was removed by vacuum. (2) 4-Dimethylaminopyridine (DMAP) and hydroxyethyl methacrylate (HEMA) were dissolved in anhydrous dichloromethane (DCM) and magnetically stirred at room temperature to allow DMAP to activate the hydroxyl groups in HEMA. (3) Dissolve the product obtained in step (1) in anhydrous DCM and slowly transfer it to the mixed solution of step (2), and stir magnetically overnight. (4) Saturated sodium bicarbonate (NaHCO3) solution is added to complete the reaction of step (3), and the mixture is acidified to pH = 2.0 with hydrochloric acid (HCl), and extracted with DCM. The organic phase is dried over anhydrous sodium sulfate (Na2SO4), filtered and concentrated in vacuo, and the crude product is purified by silica gel chromatography (Figure 1) using a mixture of methanol (MeOH) and DCM as an eluent, and finally concentrated in vacuo. (5) The oily liquid obtained in step (4) was then dissolved in anhydrous DCM and stirred with N-hydroxysuccinimide (NHS) in an ice bath. (6) 1-Ethyl-(3-(dimethylaminopropyl)carbodiimide hydrochloride) (EDC) dissolved in anhydrous DCM was added dropwise to the above mixture and stirred magnetically under nitrogen atmosphere at room temperature overnight. (7) The mixed solution is added dropwise into petroleum ether as a precipitant to obtain white floccules, which are then washed with ultrapure water, filtered and dried to obtain a powdery disulfide functional monomer.
3. The preparation method and application of the disulfide wet adhesion hydrogel according to claim 2, characterized in that: The disulfide monomer in step (1) can be diphenyl disulfide (Ph2S2), dimethyl disulfide (CH3-SS-CH3), diallyl disulfide (H2C=CH-CH2S-SCH2-CH=CH2), dithioglycolic acid (C4H6O4S2), cystine, α-lipoic acid and asparagus acid.
4. The preparation method and application of the disulfide wet adhesion hydrogel according to claim 3, characterized in that: The concentration of the disulfide monomer in step (1) is 5×10-3 to 2×10-2 mol / L; the volume of acetic anhydride in step (1) is 5 to 30 mL; the stirring rate in step (1) is 200 to 600 rpm, and the time is 2 to 6 hours. The vacuum solvent removal in step (1) is performed using a RE-52AA rotary evaporator equipped with a 2XZ-4 rotary vane vacuum pump and a DLSB-5L / 20 low-temperature coolant circulation pump; the cooling temperature of the rotary evaporation is -20°C, the water bath heating temperature is 30 to 60°C, and the rotation speed is 30 to 120 r / min. The mass of 4-dimethylaminopyridine (DMAP) in step (2) is 0.01-0.03 g; the concentration of hydroxyethyl methacrylate (HEMA) in step (2) is 5×10-3-2×10-2 mol / L; the volume of anhydrous dichloromethane (DCM) in step (2) is 8-20 mL; the stirring rate in step (2) is 300-600 rpm, and the time is 0.5-2 h. The volume of anhydrous DCM in step (3) is 8-20 mL; the stirring rate in step (3) is 300-600 rpm, and the time is 12-18 h. The volume of saturated sodium bicarbonate (NaHCO3) in step (4) is 20 to 60 mL; the concentration of hydrochloric acid (HCl) in step (4) is 1 to 10 mol / L; the instrument used for vacuum concentration in step (4) is a RE-52AA rotary evaporator equipped with a 2XZ-4 rotary vane vacuum pump and a DLSB-5L / 20 low-temperature coolant circulation pump; the cooling temperature of the rotary evaporation is -20°C, the water bath heating temperature is 30 to 60°C, and the rotation speed is 30 to 120 r / min.
5. The preparation method and application of the disulfide wet adhesion hydrogel according to claims 1 to 4, characterized in that: The volume of methanol (MeOH) and DCM used as eluents in step (4) is 1:500 to 1:
20. The volume of anhydrous DCM in step (5) is 10 to 40 mL; the concentration of N-hydroxysuccinimide (NHS) in step (5) is 5×10 -3 ~2×10 - 2 mol / L; the stirring rate in step (5) is 300-600 rpm, and the time is 0.5-2 h. The volume of anhydrous DCM in step (6) is 5-20 mL; the concentration of 1-ethyl-(3-(dimethylaminopropyl)carbodiimide hydrochloride (EDC) in step (6) is 5×10 -3 ~2×10 -2 mol / L; the stirring rate in step (6) is 300-600 rpm, and the time is 12-18 h. The volume of petroleum ether in step (7) is 300-500 mL; the ultrapure water in step (7) comes from a ULUP-IV-20TE ultrapure water machine; the volume of ultrapure water in step (7) is 300-500 mL; the ultrapure water washing condition in step (7) is ultrasonic treatment for 30 min-2 h.
6. The preparation method and application of the disulfide wet adhesion hydrogel according to claim 1, characterized in that: The gelation method of disulfide functional monomers comprises the following steps: (1) Dissolve polyvinyl alcohol 1788 (PVA) in deionized water under heating conditions. Add acrylic acid, photoinitiator and crosslinking agent to the mixed solution in sequence and stir magnetically until completely dissolved. (2) The functional monomer with disulfide is dissolved in acetone and added to the above stock solution for magnetic stirring to obtain a precursor solution. The precursor solution is injected into a glass mold with a certain spacing distance (Figure 2) and cured under ultraviolet light to obtain a wet adhesion hydrogel with disulfide functional monomer.
7. The preparation method and application of the disulfide wet adhesion hydrogel according to claim 6, characterized in that: The heating temperature in step (1) is 60-80° C.; the mass percentage of polyvinyl alcohol 1788 (PVA) in step (1) is 7-14wt%; the mass percentage of acrylic acid in step (1) is 14-35wt%; the photoinitiator in step (1) can be 2-hydroxy-2-methylpropiophenone (1173), dialkoxyacetophenone, α-hydroxyalkyl phenone, α-aminoalkyl phenone, α-ketoglutaric acid, benzophenone, 4-methyldiphenyl ketone, 4-hydroxy-2-methylpropiophen ... Benzophenone, 2,4,6-trimethylbenzophenone; the mass percentage of the photoinitiator in step (1) is 0.1-1wt%; the crosslinking agent in step (1) can be 2,5-dimethyl-2,5-di(tert-butylperoxy)hexane (AD), methylenebis(o-chloroaniline) (MOCA), quinonedioxime (QO), poly(ethylene glycol) methacrylate, poly(ethylene glycol) dimethacrylate, diisocyanate, bismaleimide and triallyl isocyanate.
8. The preparation method and application of the disulfide wet adhesion hydrogel according to claim 7, characterized in that: The mass percentage of the crosslinking agent in step (1) is 0.01-0.1wt%; the stirring rate in step (1) is 600-1000rpm, and the time is 5-30min. The mass of the NHS ester functionalized monomer with disulfide bonds in step (2) is 25-300mg; the volume of acetone in step (2) is 0.5-3mL; the instrument used for UV curing in step (2) is SCIENTZ03-II UV crosslinking instrument; The UV cross-linking device used in step (2) is used for light curing for 15 to 30 minutes. The stirring rate in step (1) is 600 to 1000 rpm for 5 to 30 minutes.
9. The preparation method and use of the disulfide wet adhesion hydrogel according to claims 1 to 8, characterized in that: The dry wet adhesive patch is used for rapid hemostasis and repair of moist tissue and organ surfaces. The hydrogel components of the adhesive layer of the wet adhesive patch (after contacting water) will form covalent bonds and hydrogen bonds at the junction when encountering the moist tissue surface, so as to achieve the purpose of tight adhesion and firm bonding.
10. The preparation method and use of the disulfide wet adhesion hydrogel according to claim 9, characterized in that: The biocompatible triggered separation of the wet adhesion hydrogel is provided ( FIG. 3 ). Since the adhesion mechanism of the wet adhesion hydrogel relies on first removing the interfacial water on the wet biological tissue surface and then physically and covalently cross-linking with the tissue surface, the triggerable separation requires the use of a trigger solution to cut off the cross-linking force between the wet adhesion hydrogel and the biological tissue surface. The configuration method of the trigger solution is as follows: (1) A certain amount of sodium bicarbonate (SBC) and glutathione (reduced form) (GSH) were dissolved in phosphate buffered saline (PBS). (2) Using a rubber-tipped dropper, take a portion of the trigger solution and apply it to the wet-adhesive hydrogel that has adhered to the surface of the biological tissue. After standing, use tweezers to peel off the triggered wet-adhesive hydrogel.
